Pioneering research into paediatric cancer
We are embarking upon a vital fundraising campaign to support work into the research of these life threatening conditions and translating that research into effective treatment and care of children.
We need to raise funds for the following priority areas:
A Vaccine for Aggressive Childhood Brain Tumours
The outcome of this project is to provide both realistic prospects of therapeutic benefit and new insight into this condition. The project involves researching and developing a pioneering new treatment for a currently hard-to-beat form of childhood cancer.
Improving the Prospects of Children with Brain Tumours
This project aims to develop more accurate childhood brain tumour diagnosis and prognosis and in so doing will allow earlier intervention, significantly reducing death and disability in this group of children.
MRD guided chemotherapy and bone marrow transplants in leukaemia
The successful treatment of childhood leukaemia involves finding a delicate balance between the toxicity of conventional therapy and disease control. This project aims to introduce the technique of analysis of minimal residual disease (MRD) in a patient's blood sample, allowing for very accurate diagnosis and definition of the most tailored and least harmful treatment possible.
Childhood Leukaemia – Why Do Blood Cells Become Leukaemic
This project will lead to a much better understanding of the role of the Tel-AML1 translocation in the onset of leukaemia in children. Through developing drugs to block the leukaemic process, the project will significantly increase in chances of children with this form of cancer making a full and event free recovery.
With your support we will be able to ensure that many more children make a full recovery and lead a normal and active life into adulthood. Together we can make new findings, develop new treatments and create new hope for more children with cancer.
If you would like to find out more about any of the projects, or talk to us about an area of particular interest, please contact Chris Chaney on 020 7239 3079.
